Published in J Bone Miner Res on February 01, 1993
Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. J Pediatr (2008) 1.83
Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev (2005) 1.80
Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am (2005) 1.56
Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int (2008) 1.50
Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group. Thorax (1994) 1.26
Bone remodeling markers: so easy to measure, so difficult to interpret. Osteoporos Int (2015) 1.08
Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis (1993) 1.05
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma. Br J Cancer (1996) 1.03
The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment. Alcohol Clin Exp Res (2004) 1.03
Effect of rhPDGF-BB on bone turnover during periodontal repair. J Clin Periodontol (2006) 1.02
Deer antlers: a zoological curiosity or the key to understanding organ regeneration in mammals? J Anat (2005) 0.99
Paget's disease of bone: diagnosis and management. BMJ (1996) 0.98
Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis. J Clin Periodontol (1998) 0.95
Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut (1995) 0.94
C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin Oral Implants Res (1998) 0.94
Biochemical evidence of myocardial fibrosis in veteran endurance athletes. Br J Sports Med (2007) 0.93
Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction. Z Kardiol (2005) 0.89
Mammalian hibernation as a model of disuse osteoporosis: the effects of physical inactivity on bone metabolism, structure, and strength. Am J Physiol Regul Integr Comp Physiol (2008) 0.88
Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip. Int Orthop (2004) 0.88
Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut (1996) 0.84
Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1999) 0.83
A cross-sectional association between bone mineral density and parathyroid hormone and other biomarkers in community-dwelling young adults: the CARDIA study. J Clin Endocrinol Metab (2013) 0.82
Recent advances in the use of serological bone formation markers to monitor callus development and fracture healing. Crit Rev Eukaryot Gene Expr (2010) 0.82
Bone metabolism in fetuses of pregnant women exposed to single and multiple courses of corticosteroids. Obstet Gynecol (2009) 0.81
Levels of bone collagen markers in preterm infants: relation to antenatal glucocorticoid treatment. J Bone Miner Metab (2007) 0.80
Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro. Graefes Arch Clin Exp Ophthalmol (1996) 0.79
Bone metabolism in pregnant women exposed to single compared with multiple courses of corticosteroids. Obstet Gynecol (2008) 0.79
Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults. Clin Biochem Rev (2014) 0.77
New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad Med J (1993) 0.77
The effects of binge-pattern alcohol consumption on orthodontic tooth movement. Dental Press J Orthod (2014) 0.75
Periodontal proteomics: wonders never cease! Int J Proteomics (2013) 0.75
A longitudinal study of the effect of heparin thromboprophylaxis during pregnancy on maternal bone metabolism. Obstet Med (2009) 0.75
Plasma levels of N-telopeptide of Type I collagen in periodontal health, disease and after treatment. Dent Res J (Isfahan) (2016) 0.75
Type I collagen as a marker of bone metabolism in sickle cell hemoglobinopathies. J Natl Med Assoc (1998) 0.75
Markers of collagen metabolism and insulin-like growth factor binding protein-1 in term infants. Arch Dis Child Fetal Neonatal Ed (2000) 0.75
Evaluation of Salivary Levels of Pyridinoline Cross Linked Carboxyterminal Telopeptide of Type I Collagen (ICTP) in Periodontal Health and Disease. J Clin Diagn Res (2015) 0.75
Relationship between Biochemical Bone Markers and Bone Mineral Density in Patients with Phenylketonuria under Restricted Diet. Iran J Pediatr (2013) 0.75
Alcaligenes eutrophus CH34 is a facultative chemolithotroph with plasmid-bound resistance to heavy metals. J Bacteriol (1985) 5.26
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum (1993) 5.05
An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell (1999) 3.54
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology (2001) 3.00
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res (2001) 2.89
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem (1990) 2.51
Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int (2007) 2.46
Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem (1993) 2.44
Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet (1994) 2.41
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int (2006) 2.33
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int (2005) 2.23
7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem (1980) 2.19
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet (1993) 2.09
Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord (1998) 2.07
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Bioavailability of calcium supplements and the effect of Vitamin D: comparisons between milk, calcium carbonate, and calcium carbonate plus vitamin D. Am J Clin Nutr (1996) 2.04
Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int (2000) 2.02
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem (1988) 2.01
Macromolecular structure of basement membrane collagens. FEBS Lett (1981) 1.96
Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr (1998) 1.94
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94
Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation (1997) 1.93
Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain (2009) 1.91
Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int (2001) 1.88
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med (2000) 1.87
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia (2005) 1.79
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int (2008) 1.78
Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer (2004) 1.73
Fracture risk associated with the use of morphine and opiates. J Intern Med (2006) 1.71
The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J Bone Miner Res (2003) 1.68
Prognostic comparison of three classifications for medullary carcinomas of the breast. Histopathology (1997) 1.64
Primary Sjögren's syndrome in north east England--a longitudinal study. Br J Rheumatol (1991) 1.64
Experimental acute salpingitis in grivet monkeys provoked by Chlamydia trachomatis. Acta Pathol Microbiol Scand B (1979) 1.63
Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5). J Biol Chem (1994) 1.62
Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol (1990) 1.61
A direct method for fast three-dimensional serial reconstruction. J Microsc (1990) 1.60
Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake. Gastroenterology (1990) 1.56
Structural diversity and domain composition of a unique collagenous fragment (intima collagen) obtained from human placenta. Biochem J (1983) 1.55
Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis. Eur J Endocrinol (1997) 1.55
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology (2008) 1.53
Aberrant type I and type III collagen gene expression in human breast cancer in vivo. J Pathol (1998) 1.53
On-site to on-line: barriers to the use of computers for continuing education. J Contin Educ Health Prof (2000) 1.50
Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49
Stereological considerations concerning the measurement of individual osteoid seams and resorption cavities. Bone Miner (1994) 1.47
Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am (1990) 1.47
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ (2000) 1.47
Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Clin Invest (2002) 1.46
Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone (1995) 1.45
Autosomal dominant osteopetrosis. Clin Orthop Relat Res (1993) 1.44
Biosynthesis of collagen and its alterations in pathological states. Med Biol (1976) 1.42
Stroke in relation to use of raloxifene and other drugs against osteoporosis. Osteoporos Int (2010) 1.42
Familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) (1994) 1.42
Collagen metabolites in the prediction of response to GH therapy in short children. Eur J Endocrinol (1997) 1.40
Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians. Calcif Tissue Int (2013) 1.40
Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int (1989) 1.39
[Costs of different intervention strategies to prevent hip fractures]. Ugeskr Laeger (1999) 1.39
Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int (2006) 1.39
Laminin. Methods Enzymol (1982) 1.37
Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone (1996) 1.37
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer (1992) 1.34
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut (2000) 1.33
Assay of collagen-galactosyltransferase and collagen-glucosyltransferase activities and preliminary characterization of enzymic reactions with transferases from chick-embryo cartilage. Eur J Biochem (1975) 1.32
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2005) 1.30
Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest (2006) 1.29
The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab (1988) 1.29
Atrial extracellular matrix remodelling in patients with atrial fibrillation. J Cell Mol Med (2008) 1.28
Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol (1995) 1.27
Activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in the liver of rats with hepatic injury. Biochem J (1974) 1.25
Fracture risk in patients treated for hyperthyroidism. Thyroid (2000) 1.25
Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis. J Bone Miner Res (1993) 1.24
Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone (1990) 1.23
Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab (1998) 1.22
Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease. Eur J Clin Invest (1985) 1.22
Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem (1996) 1.22
Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22
Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone (2002) 1.20
Silent pulmonary embolism in patients with deep venous thrombosis. Incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation. J Intern Med (1994) 1.20